about
Host responses in tissue repair and fibrosisContribution of bone marrow-derived fibrocytes to liver fibrosisIdentification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblastsA serum amyloid P-binding hydrogel speeds healing of partial thickness wounds in pigs.Serum amyloid P inhibits fibrosis through Fc gamma R-dependent monocyte-macrophage regulation in vivo.High and low molecular weight hyaluronic acid differentially regulate human fibrocyte differentiation.Trypsin potentiates human fibrocyte differentiation.Persistent lung inflammation and fibrosis in serum amyloid P component (APCs-/-) knockout miceBrain serum amyloid P levels are reduced in individuals that lack dementia while having Alzheimer's disease neuropathology.Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.Fibrocytes in health and disease.FcγRI mediates serum amyloid P inhibition of fibrocyte differentiationInvestigational approaches to therapies for idiopathic pulmonary fibrosis.Cell density sensing and size determination.New approaches to modulating idiopathic pulmonary fibrosis.Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease.Improved serum-free culture conditions for the differentiation of human and murine fibrocytes.A brief exposure to tryptase or thrombin potentiates fibrocyte differentiation in the presence of serum or serum amyloid p.Differentiation of circulating monocytes into fibroblast-like cells.Bladder perforation secondary to primary systemic amyloidosis.Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4-/- mice.Microarray analysis of Dupuytren's disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway.The Development of Serum Amyloid P as a Possible Therapeutic
P2860
Q26852800-136FE390-C20D-4E9A-B0B8-D5D207CDEC8FQ28083363-022D8053-7584-4923-AF6B-EAD9845A7E67Q33510941-B91B3BD2-2578-4555-95E9-0FC7CD30DB2DQ33772501-D8CAB61A-2C8D-4B00-A2C2-FC5648B47E90Q33782308-50E991F7-3CC4-4455-A0B8-5B2FD854B99FQ34055945-A834F41C-E432-4A48-BBA4-5667B0ED0140Q34947713-7B39C3AA-4E44-43C5-8040-5D09F18DD409Q35138521-12C7F4FF-D629-4C1F-9282-56D882366B6DQ35823366-AAF53634-4554-4364-A5A7-53BBE543EB74Q35931701-512EB256-AF44-4E6C-B9F3-11AC45C811BEQ36012618-3315C7F1-403D-4EAB-AA55-B38D3834FA60Q36232242-60F1FAB1-AD65-4DA0-8D4B-32CB93B4D896Q37742646-1B87D948-130B-4A10-A8D5-20DCDE9B2D92Q37869180-93EBB1D8-47E2-4F51-92FB-162FD0F7ECF0Q38130161-42ACE1C0-217F-4BDB-8636-784B2649D932Q41633785-1EFA7A8F-27C1-4A56-8819-D1DA2EBF542EQ41904647-8EDAADA1-6BCE-4334-865B-BF682F7646E3Q42065164-8318FAF1-0E81-4133-BB32-2E80B8AB1536Q42575931-B3CA073A-0EC7-4F27-84EE-5C8E228ADD35Q43089781-C4CD5F17-FF6E-4B5C-895F-832B5A0B49D9Q50580688-91ED6984-6B32-440F-A2B0-DCD93C4ADD41Q54484920-685A70F4-4565-49E7-94D3-4C10983FCB88Q59136382-938B23FD-BB88-46FA-9055-32C91C32F5FF
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Serum amyloid P inhibits dermal wound healing.
@ast
Serum amyloid P inhibits dermal wound healing.
@en
Serum amyloid P inhibits dermal wound healing.
@nl
type
label
Serum amyloid P inhibits dermal wound healing.
@ast
Serum amyloid P inhibits dermal wound healing.
@en
Serum amyloid P inhibits dermal wound healing.
@nl
prefLabel
Serum amyloid P inhibits dermal wound healing.
@ast
Serum amyloid P inhibits dermal wound healing.
@en
Serum amyloid P inhibits dermal wound healing.
@nl
P2093
P2860
P1476
Serum amyloid P inhibits dermal wound healing.
@en
P2093
Andre N Gay
Bindi Naik-Mathuria
C Wayne Smith
Darrell Pilling
Jeff R Crawford
Oluyinka O Olutoye
Richard H Gomer
P2860
P304
P356
10.1111/J.1524-475X.2008.00366.X
P577
2008-03-01T00:00:00Z